Merdury Biopharmaceutical Corporation (TPEX:6932)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.14
-0.19 (-2.28%)
Apr 29, 2026, 9:29 AM CST
-41.01%
Market Cap 3.52B
Revenue (ttm) n/a
Net Income (ttm) -67.23M
Shares Out 422.03M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 634,666
Open 8.33
Previous Close 8.33
Day's Range 8.14 - 8.33
52-Week Range 4.95 - 13.80
Beta -1.62
RSI 56.78
Earnings Date May 14, 2026

About Merdury Biopharmaceutical

Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. Merdury Biopharmaceutical Corporation was founded in 2019 and is headquartered in New Taipei C... [Read more]

Sector Healthcare
Founded 2019
Employees 16
Stock Exchange Taipei Exchange
Ticker Symbol 6932
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.